4D Molecular Therapeutics, Inc. - Officer Stock Options and Restricted Stock Units


2025-10-10SEC Filing 3 (0000950130-25-000195)

The filing details the stock options and restricted stock units granted to Ashoo Gupta, VP of Finance and Controller at 4D Molecular Therapeutics, Inc. The stock options include a right to buy 27,700 shares of common stock at $22.69 per share, expiring on July 8, 2034, and a right to buy 7,056 shares at $4.14 per share, expiring on March 5, 2035. The restricted stock units include 13,850 shares vesting quarterly starting June 20, 2025, and 3,528 shares vesting quarterly starting the same date. The filing also notes that Gupta owns 45,662 shares of common stock directly. The vesting schedules for these securities are detailed, with specific milestones for vesting over a four-year period.


Tickers mentioned in this filing:FDMT